trending Market Intelligence /marketintelligence/en/news-insights/trending/5cpik5j5j3nq5jjaqlrupg2 content esgSubNav
In This List

VolitionRx plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


VolitionRx plans common stock offering

VolitionRx Ltd. plans to offer and sell its common shares in an underwritten public offering.

The life sciences company plans to grant underwriters an overallotment option to buy additional shares.

Net proceeds will be used for continued product development, clinical studies, product commercialization, working capital and other general corporate purposes.

Oppenheimer & Co. Inc. is acting as the sole book-running manager for the proposed offering. National Securities Corp. is acting as a co-manager for the offering.